HYNR-CS inj, bone marrow-derived stem cells for amyotrophic lateral sclerosis
The purpose of this study was to evaluate the safety and efficacy of intrathecal delivery of autologous bone marrow-derived stem cells ("HYNR-CS inj"), for the treatment of patients with amyotrophic lateral sclerosis.
Read More
Product Information for
HYNR-CS inj, bone marrow-derived stem cells for amyotrophic lateral sclerosis